Talk2gether Program for Social Connection in Older Adults
19. august 2026 oppdatert av: Jason Burnett, The University of Texas Health Science Center, Houston
Talk2gether Program
The purpose of this study is to see if it is feasible to recruit and retain older adults in a, weekly phone call program delivered through the Harris County Precinct 2 Healthcare and Social Services Team and to see how participation in the program affect older adults' loneliness, social isolation, psychological well-being, and satisfaction, and what barriers or challenges arise during implementation
Studieoversikt
Status
Har ikke rekruttert ennå
Forhold
Intervensjon / Behandling
Studietype
Intervensjonell
Registrering (Antatt)
50
Fase
- Ikke aktuelt
Kontakter og plasseringer
Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.
Studiekontakt
- Navn: Jason Burnett, PhD
- Telefonnummer: (713) 873-4685
- E-post: Jason.Burnett@uth.tmc.edu
Studer Kontakt Backup
- Navn: Jordan Broussard
- Telefonnummer: 713 500 0321
- E-post: Jordan.Broussard@uth.tmc.edu
Studiesteder
-
-
Texas
-
Houston, Texas, Forente stater, 77030
- The University of Texas Health Science Center at Houston
-
Ta kontakt med:
- Jason Burnett, PhD
- Telefonnummer: 713-873-4685
- E-post: Jason.Burnett@uth.tmc.edu
-
Ta kontakt med:
- Jordan Broussard
- Telefonnummer: (713) 500-0321
- E-post: Jordan.Broussard@uth.tmc.edu
-
-
Deltakelseskriterier
Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Eldre voksen
Tar imot friske frivillige
Nei
Beskrivelse
Inclusion Criteria:
- able to provide informed consent
- able to speaks English or Spanish
- able to hear sufficiently using the telephone
Exclusion Criteria:
- Need for another person to consent on the participant's behalf
- suspected or confirmed decision-making capacity impairments
- uncontrolled psychiatric illnesses such as schizophrenia, paranoia, delusion, or delirium
Studieplan
Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Støttende omsorg
- Tildeling: N/A
- Intervensjonsmodell: Enkeltgruppeoppdrag
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Talk2gether program
|
Participants will be paired with a trained team member.
The team member will then initiate contact with the older adult(s) to begin 90 days of weekly social calls.
These weekly social calls will be mostly unstructured, but supported by resource and conversation guides.
At the end of 90 days, if the older adult wishes to continue to receive calls, that request will be accommodated
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Program Feasibility as assessed by number of participants recruited
Tidsramme: end of intervention (90 days after baseline)
|
end of intervention (90 days after baseline)
|
|
|
Program Feasibility as assessed by number of participants that adhered to the weekly calls
Tidsramme: end of intervention (90 days after baseline)
|
end of intervention (90 days after baseline)
|
|
|
Feasibility as assessed by number of participants that completed the program
Tidsramme: end of intervention (90 days after baseline)
|
end of intervention (90 days after baseline)
|
|
|
Feasibility as assessed by number of participants that encountered barriers or challenges as assessed by the Client Satisfaction Questionnaire (CSQ-8)
Tidsramme: end of intervention (90 days after baseline)
|
This is an 8 item questionnaire and Items 2, 4, 5, and 8 are reverse scored.
Total scores range from 8 to 32, with the higher number indicating greater satisfaction
|
end of intervention (90 days after baseline)
|
|
Feasibility as assessed by number of participants that encountered barriers or challenges as reported on the Caller and Older Adult feedback form
Tidsramme: end of intervention (90 days after baseline)
|
end of intervention (90 days after baseline)
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Change in social connectedness as assessed by the Lubben Social Network Scale-6
Tidsramme: baseline, post-intervention (Day 90)
|
This is a 6-item self-report measure assessing perceived social support and social network size from family and friends.
Each item is scored from 0 to 5, and total scores range from 0 to 30.
Higher scores indicate greater social connectedness and lower risk of social isolation
|
baseline, post-intervention (Day 90)
|
|
Change in loneliness as assessed by the Patient-Reported Outcomes Measurement Information System (PROMIS) Social Isolation scale
Tidsramme: Baseline, end of intervention (90 days)
|
This is an 8 item scale.
Each item is rated on a 5-point scale from 1(never) to 5 ( always).
Raw scores range from 8 to 40 and are converted to PROMIS T-scores, with a mean of 50 and standard deviation of 10 in the reference population.
Higher scores indicate greater perceived social isolation/loneliness.
|
Baseline, end of intervention (90 days)
|
|
Change in depressive symptoms as assessed by the Patient Health Questionnaire-2
Tidsramme: Baseline, end of intervention (90 days)
|
This is a 2-item self-report measure .
Each item is scored from 0 (not at all) to 3 (nearly every day).
Total scores range from 0 to 6, with higher scores indicating greater depressive symptom burden.
|
Baseline, end of intervention (90 days)
|
|
Change in signs of elder mistreatment as assessed by the Elder Mistreatment Screening and Response Tool (EM-SART).
Tidsramme: Baseline, end of intervention (90 days)
|
This is a 3 item questionnaire and each will be scored as either 1(yes) or 0(no) for a maximum score of 3. Higher scores or more endorsed concerns indicate a greater number of signs suggestive of elder mistreatment
|
Baseline, end of intervention (90 days)
|
|
Change in sense of purpose using the 7-item Ryff Purpose in Life Scale.
Tidsramme: Baseline, end of intervention (90 days)
|
This is a 7 item questionnaire and each item is rated on a Likert-type scale, commonly from 1(strongly disagree) to 6( strongly agree).
Negatively worded items are reverse scored, and item scores are summed to generate a total score.
Total scores range from 7 to 42, with higher scores indicating a greater sense of purpose in life.
|
Baseline, end of intervention (90 days)
|
|
Client satisfaction as assessed by the Client Satisfaction Questionnaire
Tidsramme: end of intervention (90 days)
|
This is an 8 item questionnaire.
Scores are summed across items once.
Items 2, 4, 5, and 8 are reverse scored.
Total scores range from 8 to 32, with the higher number indicating greater satisfaction
|
end of intervention (90 days)
|
Samarbeidspartnere og etterforskere
Det er her du vil finne personer og organisasjoner som er involvert i denne studien.
Etterforskere
- Hovedetterforsker: Jason Burnett, PhD, The University of Texas Health Science Center, Houston
Studierekorddatoer
Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.
Studer hoveddatoer
Studiestart (Antatt)
3. august 2026
Primær fullføring (Antatt)
3. august 2028
Studiet fullført (Antatt)
3. august 2028
Datoer for studieregistrering
Først innsendt
19. august 2026
Først innsendt som oppfylte QC-kriteriene
19. august 2026
Først lagt ut (Faktiske)
24. august 2026
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
24. august 2026
Siste oppdatering sendt inn som oppfylte QC-kriteriene
19. august 2026
Sist bekreftet
1. august 2026
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- HSC-MS-26-0434
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
NEI
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Nei
Studerer et amerikansk FDA-regulert enhetsprodukt
Nei
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .